{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Biotine : Questions médicales les plus fréquentes",
"headline": "Biotine : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Biotine : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-15",
"dateModified": "2025-04-09",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Biotine"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Coenzymes",
"url": "https://questionsmedicales.fr/mesh/D003067",
"about": {
"@type": "MedicalCondition",
"name": "Coenzymes",
"code": {
"@type": "MedicalCode",
"code": "D003067",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.211"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Biotine",
"alternateName": "Biotin",
"code": {
"@type": "MedicalCode",
"code": "D001710",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Vesa P Hytönen",
"url": "https://questionsmedicales.fr/author/Vesa%20P%20Hyt%C3%B6nen",
"affiliation": {
"@type": "Organization",
"name": "Faculty of Medicine and Health Technology and BioMediTech, Tampere University, Tampere, Finland; Fimlab Laboratories, Tampere, Finland. Electronic address: vesa.hytonen@tuni.fi."
}
},
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Ying Wang",
"url": "https://questionsmedicales.fr/author/Ying%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, China."
}
},
{
"@type": "Person",
"name": "John H T Luong",
"url": "https://questionsmedicales.fr/author/John%20H%20T%20Luong",
"affiliation": {
"@type": "Organization",
"name": "School of Chemistry and Analytical & Biological Chemistry Research Facility, University College Cork, Cork, Ireland."
}
},
{
"@type": "Person",
"name": "Amitava Dasgupta",
"url": "https://questionsmedicales.fr/author/Amitava%20Dasgupta",
"affiliation": {
"@type": "Organization",
"name": "Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, United States. Electronic address: adasgupta@kumc.edu."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Coordination of CcpA and CodY Regulators in Staphylococcus aureus USA300 Strains.",
"datePublished": "2022-11-02",
"url": "https://questionsmedicales.fr/article/36321827",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1128/msystems.00480-22"
}
},
{
"@type": "ScholarlyArticle",
"name": "Acute paronychia in a neonate secondary to clindamycin-resistant Staphylococcus aureus.",
"datePublished": "2022-09-01",
"url": "https://questionsmedicales.fr/article/36047838",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/pde.15017"
}
},
{
"@type": "ScholarlyArticle",
"name": "Culture-based determinants and outcome of Staphylococcus aureus bloodstream infections.",
"datePublished": "2022-07-22",
"url": "https://questionsmedicales.fr/article/35973315",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.diagmicrobio.2022.115772"
}
},
{
"@type": "ScholarlyArticle",
"name": "Genomic alterations involved in fluoroquinolone resistance development in Staphylococcus aureus.",
"datePublished": "2023-07-26",
"url": "https://questionsmedicales.fr/article/37494330",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0287973"
}
},
{
"@type": "ScholarlyArticle",
"name": "Fucoxanthin Potentiates the Bactericidal Activity of Cefotaxime Against Staphylococcus aureus.",
"datePublished": "2023-06-26",
"url": "https://questionsmedicales.fr/article/37365295",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00284-023-03381-2"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Enzymes et coenzymes",
"item": "https://questionsmedicales.fr/mesh/D045762"
},
{
"@type": "ListItem",
"position": 3,
"name": "Coenzymes",
"item": "https://questionsmedicales.fr/mesh/D003067"
},
{
"@type": "ListItem",
"position": 4,
"name": "Biotine",
"item": "https://questionsmedicales.fr/mesh/D001710"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Biotine - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Biotine",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-07",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Biotine",
"description": "Comment diagnostiquer une carence en biotine ?\nQuels sont les signes cliniques d'une carence ?\nLes tests génétiques sont-ils utiles ?\nQuelle est la méthode de dépistage recommandée ?\nPeut-on diagnostiquer par des symptômes seuls ?",
"url": "https://questionsmedicales.fr/mesh/D001710?mesh_terms=Staphylococcus+aureus&page=5#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Biotine",
"description": "Quels sont les symptômes d'une carence en biotine ?\nLa perte de cheveux est-elle un symptôme ?\nY a-t-il des symptômes digestifs ?\nLes troubles de l'humeur sont-ils liés ?\nLes éruptions cutanées sont-elles fréquentes ?",
"url": "https://questionsmedicales.fr/mesh/D001710?mesh_terms=Staphylococcus+aureus&page=5#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Biotine",
"description": "Comment prévenir une carence en biotine ?\nLes personnes à risque doivent-elles se supplémenter ?\nLes régimes restrictifs augmentent-ils le risque ?\nLes antibiotiques affectent-ils la biotine ?\nLes aliments transformés sont-ils un risque ?",
"url": "https://questionsmedicales.fr/mesh/D001710?mesh_terms=Staphylococcus+aureus&page=5#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Biotine",
"description": "Comment traiter une carence en biotine ?\nQuels aliments sont riches en biotine ?\nLes suppléments sont-ils nécessaires ?\nY a-t-il des effets secondaires aux suppléments ?\nCombien de temps dure le traitement ?",
"url": "https://questionsmedicales.fr/mesh/D001710?mesh_terms=Staphylococcus+aureus&page=5#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Biotine",
"description": "Quelles complications peuvent survenir ?\nLa carence peut-elle affecter le développement ?\nY a-t-il des complications à long terme ?\nLes troubles mentaux sont-ils possibles ?\nLes complications cutanées sont-elles fréquentes ?",
"url": "https://questionsmedicales.fr/mesh/D001710?mesh_terms=Staphylococcus+aureus&page=5#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Biotine",
"description": "Qui est à risque de carence en biotine ?\nLes femmes enceintes sont-elles plus à risque ?\nLes personnes âgées sont-elles vulnérables ?\nLes végétariens sont-ils à risque ?\nLes personnes avec des troubles métaboliques sont-elles à risque ?",
"url": "https://questionsmedicales.fr/mesh/D001710?mesh_terms=Staphylococcus+aureus&page=5#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une carence en biotine ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par des tests sanguins mesurant les niveaux de biotine."
}
},
{
"@type": "Question",
"name": "Quels sont les signes cliniques d'une carence ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent fatigue, dépression, éruptions cutanées et perte de cheveux."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils utiles ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent identifier des troubles métaboliques liés à la biotine."
}
},
{
"@type": "Question",
"name": "Quelle est la méthode de dépistage recommandée ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un dosage de la biotine dans le sérum est la méthode standard de dépistage."
}
},
{
"@type": "Question",
"name": "Peut-on diagnostiquer par des symptômes seuls ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les symptômes doivent être confirmés par des tests de laboratoire."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une carence en biotine ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, dépression, éruptions cutanées et troubles neurologiques."
}
},
{
"@type": "Question",
"name": "La perte de cheveux est-elle un symptôme ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la perte de cheveux est un symptôme courant d'une carence en biotine."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes digestifs ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes comme des nausées et des douleurs abdominales peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les troubles de l'humeur sont-ils liés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la dépression et l'irritabilité peuvent être des symptômes de carence."
}
},
{
"@type": "Question",
"name": "Les éruptions cutanées sont-elles fréquentes ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des éruptions cutanées, souvent rouges et squameuses, sont fréquentes."
}
},
{
"@type": "Question",
"name": "Comment prévenir une carence en biotine ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée incluant des aliments riches en biotine aide à prévenir la carence."
}
},
{
"@type": "Question",
"name": "Les personnes à risque doivent-elles se supplémenter ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes à risque, comme les femmes enceintes, devraient envisager des suppléments."
}
},
{
"@type": "Question",
"name": "Les régimes restrictifs augmentent-ils le risque ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les régimes très restrictifs peuvent augmenter le risque de carence en biotine."
}
},
{
"@type": "Question",
"name": "Les antibiotiques affectent-ils la biotine ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains antibiotiques peuvent perturber l'absorption de la biotine."
}
},
{
"@type": "Question",
"name": "Les aliments transformés sont-ils un risque ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les aliments transformés peuvent être pauvres en biotine et augmenter le risque."
}
},
{
"@type": "Question",
"name": "Comment traiter une carence en biotine ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement consiste en des suppléments de biotine et des modifications alimentaires."
}
},
{
"@type": "Question",
"name": "Quels aliments sont riches en biotine ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les œufs, les noix, le soja et les légumes à feuilles vertes sont riches en biotine."
}
},
{
"@type": "Question",
"name": "Les suppléments sont-ils nécessaires ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, dans les cas de carence, des suppléments peuvent être nécessaires."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires aux suppléments ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires sont rares, mais peuvent inclure des troubles gastro-intestinaux."
}
},
{
"@type": "Question",
"name": "Combien de temps dure le traitement ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement peut durer plusieurs semaines, selon la gravité de la carence."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des troubles neurologiques et des problèmes cutanés graves."
}
},
{
"@type": "Question",
"name": "La carence peut-elle affecter le développement ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chez les enfants, une carence peut affecter le développement physique et mental."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications à long terme ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une carence prolongée peut entraîner des problèmes de santé chroniques."
}
},
{
"@type": "Question",
"name": "Les troubles mentaux sont-ils possibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles mentaux comme la dépression peuvent être exacerbés par une carence."
}
},
{
"@type": "Question",
"name": "Les complications cutanées sont-elles fréquentes ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des complications cutanées comme des infections peuvent survenir en cas de carence."
}
},
{
"@type": "Question",
"name": "Qui est à risque de carence en biotine ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes ayant une alimentation déséquilibrée ou des troubles digestifs sont à risque."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes sont-elles plus à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les femmes enceintes ont des besoins accrus en biotine et peuvent être à risque."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles vulnérables ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées peuvent avoir des carences en raison d'une absorption réduite."
}
},
{
"@type": "Question",
"name": "Les végétariens sont-ils à risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les végétariens peuvent être à risque s'ils ne consomment pas d'aliments riches en biotine."
}
},
{
"@type": "Question",
"name": "Les personnes avec des troubles métaboliques sont-elles à risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains troubles métaboliques peuvent affecter l'absorption de la biotine."
}
}
]
}
]
}
The complex cross talk between metabolism and gene regulatory networks makes it difficult to untangle individual constituents and study their precise roles and interactions. To address this issue, we ...
Paronychia is a common inflammatory condition of the nail fold that is often associated with infection. Causes can be fungal, viral, or most commonly, bacterial. Neonatal paronychia is a rare presenta...
The objective of this study was to examine the occurrence, determinants, and outcome of S. aureus bloodstream infections (BSI) diagnosed based on single versus multiple positive initial cultures....
All adults with first episodes of mono-microbial S. aureus BSI in Queensland during 2000-2019 were included....
10,855 (67%) and 5,421 (33%) were diagnosed based on one and multiple positive initial cultures, respectively. Patients with multiple positive initial cultures were significantly younger, more likely ...
Among patients with S. aureus BSI, those diagnosed by single positive initial blood cultures have different clinical features and a higher risk for death....
Fluoroquinolone (FQ) is a potent antibiotic class. However, resistance to this class emerges quickly which hinders its application. In this study, mechanisms leading to the emergence of multidrug-resi...
S. aureus ATCC 29213 was serially exposed to ciprofloxacin (CIP), ofloxacin (OFL), or levofloxacin (LEV) at sub-minimum inhibitory concentrations (sub-MICs) for 12 days to obtain S. aureus -1 strains ...
A strong and irreversible increase of MICs was observed in all applied FQs (32 to 128 times) in all S. aureus-1 and remained 16 to 32 times in all S. aureus-2. WGS indicated 10 noticeable mutations oc...
The emergence of MDR S. aureus was associated with the mutations in the FQ-target sequences and the overexpression of efflux pump systems and their regulators....
The increasing prevalence of antimicrobial resistance (AMR) in Staphylococcus aureus against commonly used antibiotics is a major global health issue. To prevent the emergence of AMR and maintain the ...
To perform natural transformation, one of the three main Horizontal Gene Transfer mechanisms, bacteria need to enter a physiological differentiated state called genetic competence. Interestingly, new ...
Platelets are recognized as key immune effectors, but they are targets of bacterial virulence factors. In the present study, we aimed to examine the relationship between early platelet dynamics and th...
Electronic medical records of adult patients hospitalized for SAB between July 2012 and November 2020 were retrospectively reviewed for relevant demographic, laboratory, and clinical data. The outcome...
Among the 811 patients evaluated, 29% experienced thrombocytopenia on Day 1. Platelet count nadir occurred on Days 2-3 following SAB onset, and Day 4 was a determining point of platelet count trajecto...
Early platelet dynamics during SAB have prognostic significance and represent an early window for potential platelet-directed therapeutic interventions to improve outcome....
The aim was to compare the incidence of Staphylococcus aureus bacteremia in COVID-19 and non-COVID-19 adult patients during the pandemic period versus the previous two years. Also, we described the ch...
Retrospective study in our tertiary-care centre reviewing S. aureus bacteremia episodes in COVID-19 and non-COVID-19 patients through clinical records and the Microbiology Department database....
In 2018 and 2019, the incidence of S. aureus bacteremia episodes was 1.95 and 1.63 per 1000 admissions respectively. In the pandemic period, global incidence was 1.96 episodes per 1000 non-COVID-19 ad...
We showed a significantly high rates of S. aureus bacteremia incidence in COVID-19 patients and higher methicillin resistance and 15-day mortality rates than in non-COVID-19 patients....
The primary host response to Staphylococcus aureus infection occurs via complement. Complement is an elegant evolutionarily conserved system, playing essential roles in early defences by working in co...
Retrospective cohort study....
The aim was to compare the influence of 2 common vertebral osteomyelitis (VO) causing pathogens on treatment failure within the first year of diagnosis....
VO is mainly caused by Staphylococcus aureus (SA), while enterococci and streptococci (ENST) are also responsible for a significant proportion of VO, particularly in elderly patients. Data on VO cause...
We conducted a retrospective monocentric study including VO patients from 2008 to 2020. Primary outcome was treatment failure defined as death or relapse within 1 year (T1). We compared patients diagn...
Data of 130 VO patients (SA=95; ENST=35) were available at T1. Treatment failure occurred in 37% of SA patients and 23% of ENST patients. On multivariate analysis SA [odds ratio (OR): 3.12; 95% confid...
In our cohort every third patient with VO caused by SA or ENST dies within 1 year. Our findings indicate that patients with VO caused by SA, concomitant IE and/or a high Charlson comorbidity index sco...